|
|||||
|
|
Real-World Experience of Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed or Refractory Aggressive B-cell Lymphomas: A Single-Institution Experience |
|
| Affiliation: | 1. UCLA Medical Center, Hematology Oncology, Los Angeles CA;2. UCLA Medical Center, Internal Medicine, Los Angeles CA |
| Abstract: | |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ | |